In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Theranica Ltd

Latest From Theranica Ltd

Minute Insight: Theranica’s Wearable Earns Expanded FDA Clearance For Preventing Migraines

Theranica’s expanded US FDA clearance allows the company to market its prescription-based wearable as both an acute and preventive treatment for migraine headaches.

Minute Insights Digital Health

US Medicare Creates New Code For Theranica’s Headache Device

Medicare beneficiaries suffering from migraines will soon have access to an innovate drug-free treatment at the touch of their smartphones.

FDA Medicare

CMS Announces Virtual Meetings To Discuss HCPCS Codes

The US Centers for Medicare & Medicaid Services (CMS) has announced the July schedule for its virtual Healthcare Common Procedure Coding System (HCPCS) public meetings.

Medicaid Medicare

Theranica’s Smartphone-Controlled Migraine Device Earns FDA De Novo

The FDA granted a de novo clearance to Theranica’s Nerivio Migra smartphone-controlled remote electrical neuromodulation device for acute treatment of migraine headaches.

Approvals Innovation
See All

Company Information

  • Industry
  • Digital Health
  • Medical Devices
    • Rehabilitation Equipment and Devices
  • Other Names / Subsidiaries
    • Siano Mobile Silicon
    • Theranica Bio-Electronics Ltd.